Drug Trial Radar · NCT03907176
Study of Post-Herniorrhaphy Non-opioid MMA Regimens
Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
209
Actual
Start
Apr 4, 2019
Primary completion
Oct 25, 2021
Study completion Nov 22, 2021
Sponsor
- Lead sponsor
- Heron TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 8, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.
Conditions
- Analgesia
Interventions
HTX-011Drug
300 mg bupivacaine/9 mg meloxicam
Luer lock applicatorDevice
Applicator for instillation
IbuprofenDrug
600 mg
AcetaminophenDrug
1 g
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who do Not Receive an Opioid Prescription Through the Day 15 VisitTime frame: Through Day 15
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Anaheim Clinical Trials, LLC
Anaheim, California
Horizon Clinical Research
La Mesa, California
Sharp Grossmont Hospital
La Mesa, California
University of California, Irvine Medical Center
Orange, California
Parkview Community Hospital
Riverside, California
Yale University School of Medicine
New Haven, Connecticut
Medical Research of Westchester, Inc
Miami, Florida
Professional Health Care of Pinellas
St. Petersburg, Florida
University of Louisville Hospital
Louisville, Kentucky
Baylor University Medical Center
Dallas, Missouri
Washington University School of Medicine
St Louis, Missouri
Rutgers - New Jersey Medical School
Newark, New Jersey
Stony Brook University Hospital
Stony Brook, New York
Montefiore Hutchinson Campus
The Bronx, New York
M3 Emerging Medical Research, LLC
Durham, North Carolina
Cleveland Clinic Fairview
Cleveland, Ohio
Cleveland Clinic
Cleveland, Ohio
The Ohio State University Wexner Medical Center - University Hospital
Columbus, Ohio
Midwest Clinical Research Center, LLC
Dayton, Ohio
Summit Medical Group Oregon-Bend Memorial Clinic
Bend, Oregon
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania
UPMC Passavant
Pittsburgh, Pennsylvania
Baylor University Medical Center
Dallas, Texas
Hermann Drive Surgical Hospital
Houston, Texas
Houston Methodist Hospital
Houston, Texas
Plano Surgical Hospital
Plano, Texas
Endeavor Clinical Trials, LLC
San Antonio, Texas
JBR Clinical Research
Draper, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.